Print Friendly, PDF & Email

NCT/Study#

NCT01804686 /

PCI32765CAN3001-EXT

A Phase 3b, Multicenter, Open-Label, PCI-32765 (Ibrutinib) Long-Term Extension Study

DISEASE GROUP:

Lymphoma

current phase:

Phase III

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587